Insider Trading & Ownership of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Location: Boston, MA
Summary: The estimated net worth of Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is at least $110,795,354 dollars as of 18 Sep 2024. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $68.35M. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. stock worth about $24.96M. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Zenas BioPharma, Inc. and owns shares of Zenas BioPharma, Inc. (ZBIO) stock worth about $13.63M. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $3.86M.
Signature: Wellington Biomedical Innovation Master Investors (Cayman) I L.P. By: Wellington Management Company LLP, as Investment Adviser By: /s/ Jennifer C. Boylan, Authorized Signatory
All Insider Reports: All Insider Reports

Notify me when Wellington Biomedical Innovation Master Investors (Cayman) I L.P. files a new Insider Trading report.

Ownership of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Symbol	Company	Relationship	Holdings Value	Report Period
NUVL	Nuvalent, Inc.	10%+ Owner	$68,348,670	02 Aug 2021
VERV	Verve Therapeutics, Inc.	10%+ Owner	$24,955,710	21 Jun 2021
ZBIO	Zenas BioPharma, Inc.	10%+ Owner	$13,627,608	16 Sep 2024
ACRV	Acrivon Therapeutics, Inc.	10%+ Owner	$3,863,366	17 Nov 2022
ARTV	Artiva Biotherapeutics, Inc.	10%+ Owner		22 Jul 2024
BOLD	Boundless Bio, Inc.	10%+ Owner		02 Apr 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.